1. Home
  2. TLF vs NXTC Comparison

TLF vs NXTC Comparison

Compare TLF & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tandy Leather Factory Inc.

TLF

Tandy Leather Factory Inc.

N/A

Current Price

$2.64

Market Cap

19.5M

ML Signal

N/A

Logo NextCure Inc.

NXTC

NextCure Inc.

N/A

Current Price

$6.42

Market Cap

17.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TLF
NXTC
Founded
1980
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
17.3M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
TLF
NXTC
Price
$2.64
$6.42
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$23.00
AVG Volume (30 Days)
24.6K
363.5K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
32.05%
N/A
EPS Growth
1122.22
N/A
EPS
0.08
N/A
Revenue
$76,324,000.00
$22,378,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.38
N/A
Revenue Growth
2.60
N/A
52 Week Low
$2.20
$1.55
52 Week High
$3.36
$15.74

Technical Indicators

Market Signals
Indicator
TLF
NXTC
Relative Strength Index (RSI) 69.55 52.93
Support Level $2.27 $3.98
Resistance Level $2.75 $10.66
Average True Range (ATR) 0.09 0.97
MACD 0.02 -0.04
Stochastic Oscillator 66.27 49.06

Price Performance

Historical Comparison
TLF
NXTC

About TLF Tandy Leather Factory Inc.

Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, and Canada. it generates the highest revenue from the United States.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: